Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.68 |
| ▸ | CTSL | P07711 | 3/20 | 0.58 |
| ▸ | CTSS | P25774 | 3/20 | 0.58 |
| ▸ | CTSK | P43235 | 3/20 | 0.58 |
| ▸ | CTSH | P09668 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.55 |
| ▸ | GLP1R | P43220 | 3/20 | 0.55 |
| ▸ | GCGR | P47871 | 3/20 | 0.55 |
| ▸ | NMBR | P28336 | 1/20 | 0.55 |
| ▸ | GRPR | P30550 | 1/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.54 |
| ▸ | MC4R | P32245 | 1/20 | 0.54 |
| ▸ | MC5R | P33032 | 1/20 | 0.54 |
| ▸ | MC3R | P41968 | 1/20 | 0.54 |
| ▸ | MC1R | Q01726 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29793977 | 1.00 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29387436 | 0.98 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL30518949 | 0.98 | C5AR1 (0.69) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29389916 | 0.98 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29655807 | 0.98 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29794073 | 0.98 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29794089 | 0.98 | C5AR1 (0.69) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29655769 | 0.98 | C5AR1 (0.69) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL32659744 | 0.97 | C5AR1 (0.67) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29794005 | 0.97 | C5AR1 (0.66) | C5AR1CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4240756-A1 | CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED INVARIANT CD3 IMMUNOGLOBULIN SUPERFAMILY CHAIN LOCUS AND RELATED POLYNUCLEOTIDES AND METHODS | Juno Therapeutics, Inc. (US) | 2023-09-13 | — | — | EP | disclosed |
| EP-4051402-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | Juno Therapeutics GmbH (DE) | 2022-09-07 | — | — | EP | disclosed |
| WO-2022098787-A1 | CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED INVARIANT CD3 IMMUNOGLOBULIN SUPERFAMILY CHAIN LOCUS AND RELATED POLYNUCLEOTIDES AND METHODS | JUNO THERAPEUTICS, INC. (US) | 2022-05-12 | — | — | WO | disclosed |